• 

  Animal and Human Bite Wounds (19.06.2015)

  //doi.org/10.3238/arztebl.2015.0433

  Animal bites are common. 60–80% are caused by dogs, and 20–30% by cats; bites by other animals (rabbits, guinea pigs, hamsters, rats, mice) are much rarer (1–3). The victims tend to be children. Human bites account for as many as 20% of all bite...

• 

  Liquid Biopsy in Tumor Genetic Diagnosis (09.03.2018)

  //doi.org/10.3238/arztebl.2018.0169

  Liquid biopsy is a term used to describe a diagnostic approach relying on cell-free nucleic acids from bodily fluids—usually circulating free deoxyribonucleic acids (circulating free DNA, cfDNA)—which are isolated from blood, enhanced and...

• 

  One-Year Evaluation of a Neonatal Screening Program for Cystic Fibrosis in Switzerland (17.05.2013)

  //doi.org/10.3238/arztebl.2013.0356

  Since 1979, it has been possible to measure immunoreactive trypsinogen (IRT) as a simple and reliable screening test for cystic fibrosis (CF) in neonates (1, 2). The first newborn screening (NBS) programs for CF were introduced in New Zealand and...

• 

  Asperger´s Syndrome in Adulthood (30.01.2009)

  //doi.org/10.3238/arztebl.2009.0059

  Asperger's syndrome is one of the autism spectrum disorders. Asperger's patients usually display a distinctive symptom pattern. Because their ability to intuitively recognize nonverbal signals in other persons is impaired, patients are considerably...

• 

  Neonatal Screening for Metabolic and Endocrine Disorders (10.01.2011)

  //doi.org/10.3238/arztebl.2011.0011

  Screening for treatable congenital endocrinopathies and metabolic disorders is an important preventive measure that is available for all neonates in Germany. Advances in the treatment of congenital metabolic defects have led to the expansion of the...

• 

  Point-of-Care Testing in Hospitals and Primary Care (20.08.2010)

  //doi.org/10.3238/arztebl.2010.0561

  The expression “point-of-care testing” (POCT) refers to the use of the procedures of laboratory medicine in the immediate vicinity of the patient (Box 1 gif ppt). This is a recent development in laboratory medicine driven by the clinical need to...

• 

  Risks Associated With the Non-Medicinal Use of Cannabis (17.04.2015)

  //doi.org/10.3238/arztebl.2015.0271

  Recreational use of cannabis has recently been legalized in several states of the USA. At the same time, scientific research is improving our knowledge of the therapeutic potential of medicinal drugs containing cannabis (1). In this light, it is not...

• 

  From the Tattoo Studio to the Emergency Room (07.10.2016)

  //doi.org/10.3238/arztebl.2016.0672

  Subepidermal skin inking as a fashion trend has rapidly has rapidly spread throughout Western societies in the 21st century (1). Some 120 million people in North America and Europe are tattooed (2, 3). Nevertheless, tattoo-related health risks are...

• 

  Vaccination Safety Update: Long Term Side Effects Due to Vaccination And Pharmacovigilance (03.04.2009)

  //doi.org/10.3238/arztebl.2009.0248b

  We thank the authors for their clear overview of vaccine sceptics' common objections, which are helpful for everyday clinical practice. Most vaccinations and vaccination advice in Germany are given by general practitioners and pediatricians....

• 

  In Reply (02.03.2018)

  //doi.org/10.3238/arztebl.2018.0143b

  Karst and Passie highlight several problems in the discussion of the benefits of cannabis-based medications in pain medicine. Most randomized controlled trials (RCTs) that have been conducted of oral sprays containing tetrahydrocannabinol...

---

---